A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore found that deactivating a specific protein - interleukin 11 - with drugs called therapeutic antibodies, reverses inflammation and scarring of the liver in patients suffering from an untreatable type of fatty liver disease called non-alcoholic steatohepatitis .

More...